EMMA:OTC-Emmaus Life Sciences Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 0.091

Change

0.00 (0.00)%

Market Cap

USD 4.94M

Volume

N/A

Analyst Target

USD 24.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-28 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
NONOF Novo Nordisk A/S

N/A

USD 641.36B
CMXHF CSL Limited

N/A

USD 95.97B
CSLLY CSL Ltd

N/A

USD 95.20B
UCBJF UCB SA

N/A

USD 28.35B
UCBJY UCB SA ADR

N/A

USD 28.14B
ARGNF argenx SE

N/A

USD 26.71B
GNMSF Genmab A/S

N/A

USD 16.66B
IVBIY IVBIY

N/A

USD 8.23B
ZLDPF Zealand Pharma A/S

N/A

USD 7.82B
SBMFF Sino Biopharmaceutical Limited

N/A

USD 7.55B

ETFs Containing EMMA

IUFS:LSE iShares S&P 500 Financial.. 6.54 % 0.00 %

N/A

USD 1.12B
UIFS:LSE iShares S&P 500 USD Finan.. 6.54 % 0.00 %

N/A

USD 1.13B
XSFN:LSE db x-trackers MSCI USA Fi.. 6.48 % 0.00 %

N/A

USD 1.14B
XUFN:LSE db x-trackers MSCI USA Fi.. 6.48 % 0.00 %

N/A

USD 1.14B
SXLF:LSE SPDR S&P U.S. Financials .. 6.43 % 0.00 %

N/A

USD 0.37B
IYJ 6.37 % 0.42 %

N/A

N/A
IVFGC 5.90 % 0.00 %

N/A

N/A
ZFIN:CA 5.14 % 0.00 %

N/A

N/A
BFIN-U:CA 5.12 % 0.00 %

N/A

N/A
PQVG:LSE Invesco S&P 500 QVM UCITS.. 5.10 % 0.00 %

N/A

USD 0.03B
PQVM:LSE Invesco S&P 500 QVM UCITS.. 5.10 % 0.00 %

N/A

USD 0.03B
LONG:CA CI Global Longevity Econo.. 5.06 % 0.00 %

N/A

CAD 3.79M
ZINN:CA 5.05 % 0.00 %

N/A

N/A
BGU:CA Bristol Gate Concentrated.. 4.84 % 0.85 %

N/A

CAD 0.11B
FINZ 4.83 % 0.95 %

N/A

N/A
VSLU ETF Opportunities Trust -.. 4.82 % 0.00 %

N/A

USD 0.16B
TPAY 4.68 % 0.00 %

N/A

N/A
FAS Direxion Daily Financial .. 4.58 % 1.04 %

N/A

USD 2.16B
ZINT:CA 4.39 % 0.00 %

N/A

N/A
SPHQ Invesco S&P 500® Quality.. 4.35 % 0.19 %

N/A

USD 9.99B
XPND First Trust Expanded Tech.. 4.27 % 0.00 %

N/A

USD 0.02B
JOYY 4.26 % 0.00 %

N/A

N/A
HAU:CA 4.23 % 0.79 %

N/A

N/A
LINK:CA 4.02 % 0.00 %

N/A

N/A
SXQG 6 Meridian Quality Growth.. 4.00 % 0.00 %

N/A

USD 0.04B
HFT:CA 3.89 % 0.00 %

N/A

N/A
IUQA:LSE iShares Edge MSCI USA Qua.. 3.86 % 0.00 %

N/A

USD 2.88B
IUQD:LSE iShares Edge MSCI USA Qua.. 3.86 % 0.00 %

N/A

USD 2.88B
IUQF:LSE iShares Edge MSCI USA Qua.. 3.86 % 0.00 %

N/A

USD 2.88B
QUAL 3.77 % 0.15 %

N/A

N/A
GBUY Goldman Sachs Future Cons.. 3.76 % 0.00 %

N/A

USD 0.06B
XDWF:LSE db x-trackers MSCI World .. 3.75 % 0.00 %

N/A

USD 0.61B
WFIN:LSE SPDR® MSCI World Financi.. 3.74 % 0.00 %

N/A

USD 0.31B
IXG iShares Global Financials.. 3.70 % 0.46 %

N/A

USD 0.36B
STNC Stance Equity ESG Large C.. 3.68 % 0.00 %

N/A

USD 0.11B
QMJ 3.66 % 0.00 %

N/A

N/A
DUAL 3.48 % 0.00 %

N/A

N/A
HAU-U:CA 3.00 % 0.00 %

N/A

N/A
JHMF 2.96 % 0.47 %

N/A

N/A
USMC Principal U.S. Mega-Cap E.. 2.85 % 0.12 %

N/A

USD 2.45B
EBUY:F Lyxor Index Fund - Lyxor .. 2.69 % 0.00 %

N/A

USD 0.21B
UC99:LSE UBS (Irl) ETF plc - Facto.. 2.67 % 0.00 %

N/A

USD 1.69B
UQLT:LSE UBS (Irl) ETF plc - Facto.. 2.67 % 0.00 %

N/A

USD 0.02B
TCHP T. Rowe Price Blue Chip G.. 2.61 % 0.00 %

N/A

USD 0.67B
NDVG Nuveen Dividend Growth ET.. 2.59 % 0.00 %

N/A

USD 0.01B
TGRW T. Rowe Price Growth Stoc.. 2.40 % 0.00 %

N/A

USD 0.19B
UNIC:LSE Amundi MSCI Disruptive Te.. 2.38 % 0.00 %

N/A

N/A
OPPX 2.37 % 0.00 %

N/A

N/A
IWFQ:LSE iShares MSCI World Qualit.. 2.27 % 0.00 %

N/A

USD 3.81B
IWQU:LSE iShares MSCI World Qualit.. 2.27 % 0.00 %

N/A

USD 3.81B
DGIT:LSE iShares Digitalisation UC.. 2.25 % 0.00 %

N/A

USD 0.93B
DGTL:LSE iShares Digitalisation UC.. 2.24 % 0.00 %

N/A

USD 0.93B
2B79:F iShares Digitalisation UC.. 2.24 % 0.00 %

N/A

N/A
ESGY American Century Sustaina.. 2.22 % 0.00 %

N/A

USD 0.02B
VIG Vanguard Dividend Appreci.. 2.15 % 0.06 %

N/A

USD 79.96B
XDEQ:LSE Xtrackers MSCI World Qual.. 2.10 % 0.00 %

N/A

USD 1.74B
USXF iShares® ESG Advanced MS.. 1.99 % 0.00 %

N/A

USD 1.11B
XSPU:LSE Xtrackers - S&P 500 Swap .. 1.95 % 0.00 %

N/A

USD 5.21B
XSPX:LSE Xtrackers S&P 500 Swap UC.. 1.95 % 0.00 %

N/A

USD 5.17B
CGAA:CA CI Global Asset Allocatio.. 1.91 % 0.00 %

N/A

CAD 0.02B
CAPS:CA 1.85 % 0.96 %

N/A

N/A
IGSG:LSE iShares Dow Jones Global .. 1.85 % 0.00 %

N/A

USD 1.31B
IGSU:LSE iShares Dow Jones Global .. 1.85 % 0.00 %

N/A

USD 1.31B
RUE-U:CA 1.82 % 0.00 %

N/A

N/A
FLGE 1.79 % 0.00 %

N/A

N/A
XZMU:LSE Xtrackers (IE) Plc - Xtra.. 1.76 % 0.00 %

N/A

USD 8.80B
XULR:CA 1.72 % 0.00 %

N/A

N/A
LCTU BlackRock U.S. Carbon Tra.. 1.66 % 0.00 %

N/A

USD 1.25B
SUSL iShares ESG MSCI USA Lead.. 1.47 % 0.00 %

N/A

USD 1.04B
USSG Xtrackers MSCI USA ESG Le.. 1.47 % 0.00 %

N/A

USD 1.04B
QRFT QRAFT AI-Enhanced U.S. La.. 1.42 % 0.00 %

N/A

USD 0.01B
FUSA:F Fidelity UCITS SICAV - Fi.. 1.41 % 0.00 %

N/A

N/A
FUSD:F Fidelity UCITS SICAV - Fi.. 1.41 % 0.00 %

N/A

USD 0.81B
FUSU:F Fidelity UCITS SICAV - Fi.. 1.41 % 0.00 %

N/A

N/A
FUSA:LSE Fidelity US Quality Incom.. 1.40 % 0.00 %

N/A

USD 0.36B
FUSI:LSE Fidelity US Quality Incom.. 1.40 % 0.00 %

N/A

USD 1.12B
FUQA:LSE Fidelity US Quality Incom.. 1.40 % 0.00 %

N/A

USD 0.36B
FUSD:LSE Fidelity UCITS SICAV - Fi.. 1.40 % 0.00 %

N/A

USD 1.12B
FUSP:LSE Fidelity US Quality Incom.. 1.40 % 0.00 %

N/A

USD 6.29M
XZW0:XETRA Xtrackers MSCI World ESG .. 1.25 % 0.00 %

N/A

USD 2.15B
XZW0:LSE Xtrackers MSCI World ESG .. 1.24 % 0.00 %

N/A

USD 6.73B
XESW:LSE Xtrackers (IE) Plc - Xtra.. 1.24 % 0.00 %

N/A

USD 6.71B
RWCD 1.15 % 0.00 %

N/A

N/A
UIQM:XETRA 0.87 % 0.00 %

N/A

N/A
TDV 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.00% 55% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.00% 56% F 39% F
Trailing 12 Months  
Capital Gain -60.43% 34% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -60.43% 34% F 17% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -38.55% 12% F 4% F
Dividend Return -38.55% 12% F 4% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 40.71% 73% C 58% F
Risk Adjusted Return -94.70% 15% F 6% D-
Market Capitalization 4.94M 43% F 32% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.